China National Pharmaceutical Acquires EdiBio for $1.654 Billion
June 4, 2026 — 23:20 CST
This Data Is Locked!
This area is available only to Subscribers.
China National Pharmaceutical, a state-owned medical giant, has secured the controlling stake of EdiBio, the leading domestic oncology companion diagnostics company, after a two-day trading... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
